Series B funding round for Enveda Biosciences raising $55M in December 2022
Series B funding round for Enveda Biosciences raising $55M in December 2022
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Henry Kravis |
| Angel | rajiv chegu |
| Angel | Jonathan Milner |
| Angel | Chris Gibson |
This company has completed 6 funding rounds. Current round is highlighted.
Total Raised
$442M
Top Valuation
-
Enveda Biosciences raised $55M in a Series B round.
The round was announced on 12/01/22.